insights_auto
Why is ORX up 2,67%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,08 SEK
arrow_upward
+2,67%(+0,028) 1D
10 қар., 17:29:51 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,06 SEK
High
1,15 SEK
Low
0,91 SEK
Mkt. cap
377,25 млн
Avg. vol.
582,45 м.
Volume
956,12 м.
P/E ratio
0,05
52-wk high
22,55 SEK
52-wk low
0,81 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,06 SEK
High
1,15 SEK
Low
0,91 SEK
Mkt. cap
377,25 млн
Avg. vol.
582,45 м.
Volume
956,12 м.
P/E ratio
0,05
52-wk high
22,55 SEK
52-wk low
0,81 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Yahoo Finance
·
18 минут бұрын
Amazon’s Cloud Computing Business Already Brings in More Revenue Than 476 Companies in the S&P 500. Here’s What It Would Take to Reach $1 Trillion.
ChartMill
·
1 сағат бұрын
Rigetti Computing (NASDAQ:RGTI) Falls After Q3 Revenue Miss and Light 2026 Guidance
TheStreet
·
36 минут бұрын
Citigroup CEO offers bold S&P 500 prediction
AP News
·
9 сағат бұрын
Inflation runs hotter than expected as higher prices extend beyond the gas station
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com